myers iv and glutathione Therapy Myer's Cocktail IV Therapy |
Description
Akira Yokoyama, Hoichi Kato, Tetsuji Yokoyama, Toshimasa Tsujinaka, Manabu Muto, Tai Omori, Tatsumasa Haneda, Yoshiya Kumagai, Hiroyasu Igaki, Masako Yokoyama, Hiroshi Watanabe, Haruhiko Fukuda, Haruko Yoshimizu

Conclusion: This case highlights that patients with LS-EC who are carriers of combined EPCAM-MSH2 deletion might experience better oncologic outcomes even with early recurrence

[DOI] [PMC free article] [PubMed] [Google Scholar] 90.Karimi F., Omrani G.R

Maini, R